These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 33749383)
1. Lineage Switch in an Infant B-Lymphoblastic Leukemia With t(1;11)(p32;q23); Du J; Chisholm KM; Tsuchiya K; Leger K; Lee BM; Rutledge JC; Paschal CR; Summers C; Xu M Pediatr Dev Pathol; 2021; 24(4):378-382. PubMed ID: 33749383 [TBL] [Abstract][Full Text] [Related]
2. Lineage Switch in MLL-Rearranged Infant Leukemia Following CD19-Directed Therapy. Rayes A; McMasters RL; O'Brien MM Pediatr Blood Cancer; 2016 Jun; 63(6):1113-5. PubMed ID: 26914337 [TBL] [Abstract][Full Text] [Related]
3. Lineage switch under blinatumomab treatment of relapsed common acute lymphoblastic leukemia without MLL rearrangement. Zoghbi A; Zur Stadt U; Winkler B; Müller I; Escherich G Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28453885 [TBL] [Abstract][Full Text] [Related]
4. Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in Wölfl M; Rasche M; Eyrich M; Schmid R; Reinhardt D; Schlegel PG Blood Adv; 2018 Jun; 2(12):1382-1385. PubMed ID: 29898879 [TBL] [Abstract][Full Text] [Related]
5. Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis. Haddox CL; Mangaonkar AA; Chen D; Shi M; He R; Oliveira JL; Litzow MR; Al-Kali A; Hogan WJ; Elliott MA Blood Cancer J; 2017 Sep; 7(9):e607. PubMed ID: 29016570 [No Abstract] [Full Text] [Related]
6. Extramedullary relapse of Aldoss I; Song JY Blood; 2018 May; 131(22):2507. PubMed ID: 29853461 [No Abstract] [Full Text] [Related]
7. Therapy-induced Deletion in 11q23 Leading to Fusion of Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897 [TBL] [Abstract][Full Text] [Related]
8. Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to acute myeloid leukemia. Bełdzińska-Gądek K; Zarzycka E; Pastuszak K; Borman K; Lewandowski K; Zaucha JM; Prejzner W Leuk Lymphoma; 2024 Sep; 65(9):1292-1302. PubMed ID: 38775354 [TBL] [Abstract][Full Text] [Related]
9. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia. Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023 [TBL] [Abstract][Full Text] [Related]
10. Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy. Gardner R; Wu D; Cherian S; Fang M; Hanafi LA; Finney O; Smithers H; Jensen MC; Riddell SR; Maloney DG; Turtle CJ Blood; 2016 May; 127(20):2406-10. PubMed ID: 26907630 [TBL] [Abstract][Full Text] [Related]
16. Expression of a novel type of KMT2A/EPS15 fusion transcript in FLT3 mutation-positive B-lymphoblastic leukemia with t(1;11)(p32;q23). Yamamoto K; Yakushijin K; Mizutani Y; Okuni-Watanabe M; Goto H; Higashime A; Miyata Y; Kitao A; Matsumoto H; Saegusa J; Matsuoka H; Minami H Cancer Genet; 2021 Jun; 254-255():92-97. PubMed ID: 33647817 [TBL] [Abstract][Full Text] [Related]
17. Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report. McGrath M; Smink G J Med Case Rep; 2021 May; 15(1):228. PubMed ID: 33957966 [TBL] [Abstract][Full Text] [Related]